Literature DB >> 17621549

Transcriptional activation of MMP-13 by periodontal pathogenic LPS requires p38 MAP kinase.

Carlos Rossa1, Min Liu, Paul Bronson, Keith L Kirkwood.   

Abstract

Matrix metalloprotease-13 (MMP-13) is induced by pro-inflammatory cytokines and increased expression is associated with a number of pathological conditions such as tumor metastasis, osteoarthritis, rheumatoid arthritis and periodontal diseases. MMP-13 gene regulation and the signal transduction pathways activated in response to bacterial LPS are largely unknown. In these studies, the role of the mitogen-activated protein kinase (MAPK) pathways in the regulation of MMP-13 induced by lipopolysaccharide was investigated. Lipopolysaccharide from Escherichia coli and Actinobacillus actinomycetemcomitans significantly (P < 0.05) increased MMP-13 steady-state mRNA (average of 27% and 46% increase, respectively) in murine periodontal ligament fibroblasts. MMP-13 mRNA induction was significantly reduced by inhibition of p38 MAP kinase. Immunoblot analysis indicated that p38 signaling was required for LPS-induced MMP-13 expression. Lipopolysaccharide induced proximal promoter reporter (-660/+32 mMMP-13) gene activity required p38 signaling. Collectively, these results indicate that lipopolysaccharide-induced murine MMP-13 is regulated by p38 signaling through a transcriptional mechanism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17621549     DOI: 10.1177/0968051907079118

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  14 in total

Review 1.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

2.  Gene coexpression analysis reveals dose-dependent and type-specific networks responding to ionizing radiation in the aquatic model plant Lemna minor using public data.

Authors:  Lili Fu; Zehong Ding; Anuwat Kumpeangkeaw; Xuepiao Sun; Jiaming Zhang
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.

Authors:  Michael S Valerio; Frank Alexis; Keith L Kirkwood
Journal:  J Periodontol       Date:  2019-03-13       Impact factor: 6.993

4.  Silencing mitogen-activated protein kinase-activated protein kinase-2 arrests inflammatory bone loss.

Authors:  Qiyan Li; Hong Yu; Robert Zinna; Kylie Martin; Bethany Herbert; Angen Liu; Carlos Rossa; Keith L Kirkwood
Journal:  J Pharmacol Exp Ther       Date:  2010-12-07       Impact factor: 4.030

5.  Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo.

Authors:  M R Guimarães; L S Coimbra; S G de Aquino; L C Spolidorio; K L Kirkwood; C Rossa
Journal:  J Periodontal Res       Date:  2011-02-08       Impact factor: 4.419

Review 6.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

7.  S100A4 upregulation suppresses tissue ossification and enhances matrix degradation in experimental periodontitis models.

Authors:  Min Zhou; Zhuo-quan Li; Zuo-lin Wang
Journal:  Acta Pharmacol Sin       Date:  2015-10-26       Impact factor: 6.150

8.  Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin.

Authors:  Ryan Serra; Abdel-Ghany Al-Saidi; Nikola Angelov; Salvador Nares
Journal:  J Inflamm (Lond)       Date:  2010-09-15       Impact factor: 4.981

Review 9.  Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock.

Authors:  Ineke Vanlaere; Claude Libert
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

10.  A critical role for suppressors of cytokine signaling 3 in regulating LPS-induced transcriptional activation of matrix metalloproteinase-13 in osteoblasts.

Authors:  Anqi Gao; Alpdogan Kantarci; Bruno Schneider Herrera; Hongwei Gao; Thomas E Van Dyke
Journal:  PeerJ       Date:  2013-03-05       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.